Aclarion, Inc. financial data

Symbol
ACON, ACONW on Nasdaq
Industry
Services-Medical Laboratories
Location
8181 Arista Place, Ste 100, Broomfield, CO
State of incorporation
DE
Fiscal year end
December 31
Former names
Nocimed, Inc. (to 10/26/2021)
Latest financial report
10-Q - Q3 2024 - Nov 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 116 % +89.7%
Debt-to-equity 110 %
Return On Equity -423 % +41.7%
Return On Assets -201 % +8.8%
Operating Margin -9.81K % -75.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 10.4M shares +27.2%
Common Stock, Shares, Outstanding 10M shares +22%
Entity Public Float 4.67M USD -6.91%
Common Stock, Value, Issued 100 USD +22%
Weighted Average Number of Shares Outstanding, Basic 9.44M shares +1671%
Weighted Average Number of Shares Outstanding, Diluted 9.44M shares +1671%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 49.3K USD -41.4%
Cost of Revenue 83.5K USD +13.5%
Research and Development Expense 858K USD -1.61%
Selling and Marketing Expense 818K USD +13.2%
General and Administrative Expense 3.12M USD +0.48%
Operating Income (Loss) -4.83M USD -3.01%
Nonoperating Income (Expense) -1.44M USD -1515%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -6.27M USD -36.9%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -6.27M USD -36.6%
Earnings Per Share, Basic -2.47 USD/shares +90%
Earnings Per Share, Diluted -2.47 USD/shares +90%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 1.31M USD
Accounts Receivable, after Allowance for Credit Loss, Current 17K USD -20%
Assets, Current 1.9M USD +420%
Property, Plant and Equipment, Net 892 USD -56.8%
Intangible Assets, Net (Excluding Goodwill) 1.29M USD +9.66%
Assets 3.19M USD +107%
Accounts Payable, Current 332K USD -51.7%
Accrued Liabilities, Current 12.1K USD
Liabilities, Current 678K USD -71.4%
Liabilities 678K USD
Retained Earnings (Accumulated Deficit) -49.3M USD -14.5%
Stockholders' Equity Attributable to Parent 2.51M USD
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 0 USD
Liabilities and Equity 3.19M USD +107%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -2.24M USD -121%
Net Cash Provided by (Used in) Financing Activities 3.41M USD
Net Cash Provided by (Used in) Investing Activities -63.7K USD -443%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 10M shares +22%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 1.32M USD +671%
Deferred Tax Assets, Valuation Allowance 9.71M USD
Deferred Tax Assets, Gross 9.71M USD
Property, Plant and Equipment, Gross 55.2K USD -24.8%
Deferred Tax Assets, Operating Loss Carryforwards 9.24M USD
Preferred Stock, Shares Authorized 20M shares 0%
Additional Paid in Capital 51.8M USD +22.7%
Amortization of Intangible Assets 182K USD +24.6%
Depreciation, Depletion and Amortization 45.1K USD +14.6%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Share-based Payment Arrangement, Expense 702K USD +14725%
Interest Expense 943K USD -30%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%